These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 31657834)

  • 1. Selective Vulnerability of the Nucleus Basalis of Meynert Among Neuropathologic Subtypes of Alzheimer Disease.
    Hanna Al-Shaikh FS; Duara R; Crook JE; Lesser ER; Schaeverbeke J; Hinkle KM; Ross OA; Ertekin-Taner N; Pedraza O; Dickson DW; Graff-Radford NR; Murray ME
    JAMA Neurol; 2020 Feb; 77(2):225-233. PubMed ID: 31657834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropathologically defined subtypes of Alzheimer's disease differ significantly from neurofibrillary tangle-predominant dementia.
    Janocko NJ; Brodersen KA; Soto-Ortolaza AI; Ross OA; Liesinger AM; Duara R; Graff-Radford NR; Dickson DW; Murray ME
    Acta Neuropathol; 2012 Nov; 124(5):681-92. PubMed ID: 22968369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic Heterogeneity and Glial Activation Patterns in Alzheimer Disease.
    Kouri N; Frankenhauser I; Peng Z; Labuzan SA; Boon BDC; Moloney CM; Pottier C; Wickland DP; Caetano-Anolles K; Corriveau-Lecavalier N; Tranovich JF; Wood AC; Hinkle KM; Lincoln SJ; Spychalla AJ; Senjem ML; Przybelski SA; Engelberg-Cook E; Schwarz CG; Kwan RS; Lesser ER; Crook JE; Carter RE; Ross OA; Lachner C; Ertekin-Taner N; Ferman TJ; Fields JA; Machulda MM; Ramanan VK; Nguyen AT; Reichard RR; Jones DT; Graff-Radford J; Boeve BF; Knopman DS; Petersen RC; Jack CR; Kantarci K; Day GS; Duara R; Graff-Radford NR; Dickson DW; Lowe VJ; Vemuri P; Murray ME
    JAMA Neurol; 2024 Jun; 81(6):619-629. PubMed ID: 38619853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretangle pathology within cholinergic nucleus basalis neurons coincides with neurotrophic and neurotransmitter receptor gene dysregulation during the progression of Alzheimer's disease.
    Tiernan CT; Ginsberg SD; He B; Ward SM; Guillozet-Bongaarts AL; Kanaan NM; Mufson EJ; Counts SE
    Neurobiol Dis; 2018 Sep; 117():125-136. PubMed ID: 29859871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study.
    Murray ME; Graff-Radford NR; Ross OA; Petersen RC; Duara R; Dickson DW
    Lancet Neurol; 2011 Sep; 10(9):785-96. PubMed ID: 21802369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HDAC2 dysregulation in the nucleus basalis of Meynert during the progression of Alzheimer's disease.
    Mahady L; Nadeem M; Malek-Ahmadi M; Chen K; Perez SE; Mufson EJ
    Neuropathol Appl Neurobiol; 2019 Jun; 45(4):380-397. PubMed ID: 30252960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tau Oligomer Pathology in Nucleus Basalis Neurons During the Progression of Alzheimer Disease.
    Tiernan CT; Mufson EJ; Kanaan NM; Counts SE
    J Neuropathol Exp Neurol; 2018 Mar; 77(3):246-259. PubMed ID: 29378005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein homeostasis gene dysregulation in pretangle-bearing nucleus basalis neurons during the progression of Alzheimer's disease.
    Tiernan CT; Ginsberg SD; Guillozet-Bongaarts AL; Ward SM; He B; Kanaan NM; Mufson EJ; Binder LI; Counts SE
    Neurobiol Aging; 2016 Jun; 42():80-90. PubMed ID: 27143424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective Evaluation of Neuropathologic Proxies of the Minimal Atrophy Subtype Compared With Corticolimbic Alzheimer Disease Subtypes.
    Boon BDC; Labuzan SA; Peng Z; Matchett BJ; Kouri N; Hinkle KM; Lachner C; Ross OA; Ertekin-Taner N; Carter RE; Ferman TJ; Duara R; Dickson DW; Graff-Radford NR; Murray ME
    Neurology; 2023 Oct; 101(14):e1412-e1423. PubMed ID: 37580158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's disease clinical variants show distinct regional patterns of neurofibrillary tangle accumulation.
    Petersen C; Nolan AL; de Paula França Resende E; Miller Z; Ehrenberg AJ; Gorno-Tempini ML; Rosen HJ; Kramer JH; Spina S; Rabinovici GD; Miller BL; Seeley WW; Heinsen H; Grinberg LT
    Acta Neuropathol; 2019 Oct; 138(4):597-612. PubMed ID: 31250152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression of tau pathology within cholinergic nucleus basalis neurons in chronic traumatic encephalopathy: A chronic effects of neurotrauma consortium study.
    Mufson EJ; Perez SE; Nadeem M; Mahady L; Kanaan NM; Abrahamson EE; Ikonomovic MD; Crawford F; Alvarez V; Stein T; McKee AC
    Brain Inj; 2016; 30(12):1399-1413. PubMed ID: 27834536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined in vivo MRI assessment of locus coeruleus and nucleus basalis of Meynert integrity in amnestic Alzheimer's disease, suspected-LATE and frontotemporal dementia.
    Lagarde J; Olivieri P; Tonietto M; Noiray C; Lehericy S; Valabrègue R; Caillé F; Gervais P; Moussion M; Bottlaender M; Sarazin M
    Alzheimers Res Ther; 2024 May; 16(1):97. PubMed ID: 38702802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex and age interact to determine clinicopathologic differences in Alzheimer's disease.
    Liesinger AM; Graff-Radford NR; Duara R; Carter RE; Hanna Al-Shaikh FS; Koga S; Hinkle KM; DiLello SK; Johnson MF; Aziz A; Ertekin-Taner N; Ross OA; Dickson DW; Murray ME
    Acta Neuropathol; 2018 Dec; 136(6):873-885. PubMed ID: 30219939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease.
    Tiraboschi P; Hansen LA; Masliah E; Alford M; Thal LJ; Corey-Bloom J
    Neurology; 2004 Jun; 62(11):1977-83. PubMed ID: 15184600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurofibrillary degeneration of cholinergic and noncholinergic neurons of the basal forebrain in Alzheimer's disease.
    Rasool CG; Svendsen CN; Selkoe DJ
    Ann Neurol; 1986 Oct; 20(4):482-8. PubMed ID: 3539000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Neurofibrillary Tangle Distribution With Age at Onset-Related Clinical Heterogeneity in Alzheimer Disease: An Autopsy Study.
    Smirnov DS; Salmon DP; Galasko D; Goodwill VS; Hansen LA; Zhao Y; Edland SD; Léger GC; Peavy GM; Jacobs DM; Rissman R; Pizzo DP; Hiniker A
    Neurology; 2022 Feb; 98(5):e506-e517. PubMed ID: 34810247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ApoE epsilon4 genotype is accompanied by lower metabolic activity in nucleus basalis of Meynert neurons in Alzheimer patients and controls as indicated by the size of the Golgi apparatus.
    Dubelaar EJ; Verwer RW; Hofman MA; Van Heerikhuize JJ; Ravid R; Swaab DE
    J Neuropathol Exp Neurol; 2004 Feb; 63(2):159-69. PubMed ID: 14989602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene Profiling of Nucleus Basalis Tau Containing Neurons in Chronic Traumatic Encephalopathy: A Chronic Effects of Neurotrauma Consortium Study.
    Mufson EJ; He B; Ginsberg SD; Carper BA; Bieler GS; Crawford F; Alvarez VE; Huber BR; Stein TD; McKee AC; Perez SE
    J Neurotrauma; 2018 Jun; 35(11):1260-1271. PubMed ID: 29338612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleus basalis of Meynert modulates signal processing in rat layer 5 somatosensory cortex but leads to memory impairment and tactile discrimination deficits following lesion.
    Goshadrou F; Sadeghi B
    Behav Brain Res; 2020 May; 386():112608. PubMed ID: 32194192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholinergic nucleus basalis tauopathy emerges early in the aging-MCI-AD continuum.
    Mesulam M; Shaw P; Mash D; Weintraub S
    Ann Neurol; 2004 Jun; 55(6):815-28. PubMed ID: 15174015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.